BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 6986977)

  • 1. Detection of cytoplasmic immunologlobulin in well-differentiated lymphoproliferative diseases by the immunoperoxidase method.
    Pangalis GA; Nathwani BN; Rappaport H
    Cancer; 1980 Mar; 45(6):1334-9. PubMed ID: 6986977
    [No Abstract]   [Full Text] [Related]  

  • 2. B-lymphoproliferative disorders: a proposed unified pathogenetic pathway.
    Ezdinli EZ; Nanus DM
    Hematol Oncol; 1983; 1(4):297-319. PubMed ID: 6429025
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Immunoglobulins in lymphoproliferative diseases. I. A study of serum and surface immunoglobulins in chronic lympholeukemia].
    Kharchenko MF; Moiseeva VP; Khodzhakulieva AM; Rybakova LP; Rozanova LM
    Zdravookhr Kirg; 1980; (1):34-8. PubMed ID: 6103611
    [No Abstract]   [Full Text] [Related]  

  • 4. [The study of intracellular immunoglobulins by the immunoperoxidase method in lymphoproliferative diseases].
    Soboleva TN; Lugovskaia SA; Morozova VT; Lukina EA; Mokeeva RA
    Gematol Transfuziol; 1986 Aug; 31(8):27-33. PubMed ID: 3530874
    [No Abstract]   [Full Text] [Related]  

  • 5. Comparison of immunofluorescence and immunoperoxidase techniques for demonstration of phenotype and monoclonality in lymphoproliferative disorders.
    Marsden KA; Lowenthal RM
    Clin Lab Haematol; 1987; 9(3):297-306. PubMed ID: 3308290
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Immunologic cell markers in lymphoproliferative diseases].
    Samoĭlova RS
    Ter Arkh; 1980; 52(9):140-9. PubMed ID: 7001662
    [No Abstract]   [Full Text] [Related]  

  • 7. Immunoperoxidase staining of surface and intracellular immunoglobulin in human neoplastic lymphoid cells.
    Mason DY; Leonard RC; Laurent G; Gourdin MF
    J Clin Pathol; 1980 Jul; 33(7):609-16. PubMed ID: 7000833
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Childhood lymphoma-leukemia. I. Correlation of morphology and immunological studies.
    Williams AH; Taylor CR; Higgins GR; Quinn JJ; Schneider BK; Swansson V; Parker JW; Pattengale PK; Chandor SB; Powars D; Lincoln TL; Tindle BH; Lukes RJ
    Cancer; 1978 Jul; 42(1):171-81. PubMed ID: 352504
    [No Abstract]   [Full Text] [Related]  

  • 9. Distribution of lymphocytes with interleukin-2 receptors (TAC antigens) in reactive lymphoproliferative processes, Hodgkin's disease, and non-Hodgkin's lymphomas. An immunohistologic study of 300 cases.
    Sheibani K; Winberg CD; van de Velde S; Blayney DW; Rappaport H
    Am J Pathol; 1987 Apr; 127(1):27-37. PubMed ID: 3105322
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Concurrent development of preleukaemic, lymphoproliferative and plasma cell disorders.
    Greenberg BR; Miller C; Cardiff RD; MacKenzie MR; Walling P
    Br J Haematol; 1983 Jan; 53(1):125-33. PubMed ID: 6216909
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunohistologic studies of cytoplasmic immunoglobulins in rheumatic diseases including two patients with monoclonal patterns and subsequent lymphoma.
    Humphrey DM; Cortez EA; Spiva DA
    Cancer; 1982 May; 49(10):2049-69. PubMed ID: 6804080
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lymphocytic lymphoma/B-chronic lymphocytic leukaemia--an immunohistopathological study of peripheral B lymphocyte neoplasia.
    Swerdlow SH; Murray LJ; Habeshaw JA; Stansfeld AG
    Br J Cancer; 1984 Nov; 50(5):587-99. PubMed ID: 6388614
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical spectrum of lymphoproliferative diseases.
    Galton DA; Catovsky D; Wiltshaw E
    Cancer; 1978 Aug; 42(2 Suppl):901-10. PubMed ID: 581182
    [No Abstract]   [Full Text] [Related]  

  • 14. [Characteristics of malignant lymphoproliferative syndromes in the aged].
    Popa G; Popa M; Iordăcheanu L
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1977; 29(4):359-62. PubMed ID: 22918
    [No Abstract]   [Full Text] [Related]  

  • 15. Systemic lymphoproliferative disorder with morphologic features of Castleman's disease. Immunoperoxidase study of cytoplasmic immunoglobulins.
    Miller RT; Mukai K; Banks PM; Frizzera G
    Arch Pathol Lab Med; 1984 Aug; 108(8):626-30. PubMed ID: 6204622
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Redistribution of immunoglobulin determinants on human lymphocytes in lymphoproliferative disorders.
    Huber C; Michlmayr G; Braunsteiner H; Huber H
    Eur J Cancer (1965); 1974 Aug; 10(8):517-21. PubMed ID: 4142759
    [No Abstract]   [Full Text] [Related]  

  • 17. [Reactivity of the lymphocytes of lymph nodes in cases of malignant lymphoma to plant agglutinin].
    Stramignoni A; Navone R; Meriggi E
    Boll Soc Ital Biol Sper; 1969 Feb; 45(3):194-6. PubMed ID: 4899663
    [No Abstract]   [Full Text] [Related]  

  • 18. Lymphocyte surface markers in lymphoproliferative disorders.
    Aiuti F; Lacava V; Fiorilli M; Ciarla MV
    Acta Haematol; 1973; 50(5):275-83. PubMed ID: 4202631
    [No Abstract]   [Full Text] [Related]  

  • 19. [Clinical manifestations of lymphoproliferative disorders of thymic origin].
    Pintado Cros T
    Sangre (Barc); 1984; 29(4-C):731-40. PubMed ID: 6240122
    [No Abstract]   [Full Text] [Related]  

  • 20. Present nosography of lymphoproliferative disorders.
    Raphael M; Binet JL
    Acta Haematol; 1987; 78 Suppl 1():142-5. PubMed ID: 2893505
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.